سه شنبه 23 تیر 1405
[Archive]
پذیرفته شده و در حال انتشار
برگشت به فهرست مقالات |
برگشت به فهرست نسخه ها
Ethics code: IR.MUBABOL.HRI.REC.1400.234
چکیده: (120 مشاهده)
Background and Objectives: Co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and either respiratory syncytial virus (RSV) or influenza virus may increase disease severity in children compared with single infections. In the present study, frequency of SARS-CoV-2, RSV, and Influenza virus infections and co-infections was examined and compared with the patients' laboratory and clinical characteristics.
Materials and Methods: Three hundred thirty-seven upper respiratory swab samples were obtained from hospitalized pediatric patients. Multiplex real-time RT-PCR was utilized as a diagnostic technique to identify the presence of SARS-CoV-2, RSV, and the Influenza virus. The comparison of SARS-CoV2, RSV and influenza virus-positive groups were done by considering symptoms, clinical characteristics, and laboratory findings
Results: SARS-CoV-2, RSV, and influenza virus were detected in 18 (5.3%), 9 (2.7%), and 34 (10.1%) of the 337 hospitalized children. Three cases of influenza virus and RSV mixed infection were found, and one case of SARS-CoV-2 and influenza virus co-infection was found. Fever in the influenza and SARS-CoV-2 positive groups was substantially greater than in the RSV positive group in terms of symptoms upon hospital admission (p = 0.024). Additionally, compared to RSV and influenza virus-positive groups, a significantly larger proportion of cases in the SARS-CoV-2 positive group reported fatigue (p = 0.032).
Conclusion: SARS-CoV-2/Influenza virus co-infection and RSV/Influenza mixed infection cases exhibited minor respiratory symptoms, as did the all-respiratory viral co-infected patients. In our cohort, all four patients with respiratory viral co-infections (one SARS-CoV-2/Influenza and three RSV/Influenza) presented with mild respiratory disease, similar to the majority of single-infected cases.
Materials and Methods: Three hundred thirty-seven upper respiratory swab samples were obtained from hospitalized pediatric patients. Multiplex real-time RT-PCR was utilized as a diagnostic technique to identify the presence of SARS-CoV-2, RSV, and the Influenza virus. The comparison of SARS-CoV2, RSV and influenza virus-positive groups were done by considering symptoms, clinical characteristics, and laboratory findings
Results: SARS-CoV-2, RSV, and influenza virus were detected in 18 (5.3%), 9 (2.7%), and 34 (10.1%) of the 337 hospitalized children. Three cases of influenza virus and RSV mixed infection were found, and one case of SARS-CoV-2 and influenza virus co-infection was found. Fever in the influenza and SARS-CoV-2 positive groups was substantially greater than in the RSV positive group in terms of symptoms upon hospital admission (p = 0.024). Additionally, compared to RSV and influenza virus-positive groups, a significantly larger proportion of cases in the SARS-CoV-2 positive group reported fatigue (p = 0.032).
Conclusion: SARS-CoV-2/Influenza virus co-infection and RSV/Influenza mixed infection cases exhibited minor respiratory symptoms, as did the all-respiratory viral co-infected patients. In our cohort, all four patients with respiratory viral co-infections (one SARS-CoV-2/Influenza and three RSV/Influenza) presented with mild respiratory disease, similar to the majority of single-infected cases.
فهرست منابع
1. Howley PM, Knipe DM. Fields virology: Emerging viruses: Lippincott Williams & Wilkins; 2020.
2. Mohammad W, Al Sayeh A. mRNA Vaccines Beyond COVID-19: Emerging therapeutic frontiers. Trend Pharmaceut Biotechnol. 2024;2(2):30-7. [DOI:10.57238/tpb.2024.153196.1020]
3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Eng J Med. 2020;382(8):727-33 [DOI:10.1056/NEJMoa2001017] [PMID] [PMCID]
4. Mohammadi M, Yahyapour Y, Nasrollahian S, Tayefeh-Arbab MH, Javanian M, Rajabi Fadardi M, et al. A Review on herbal secondary metabolites against COVID-19 focusing on the genetic variants of SARS-CoV-2. Jundishapur J Nat Pharm Prod. 2022;17(4):e129618. [DOI:10.5812/jjnpp-129618]
5. Caini S, Kroneman M, Wiegers T, El Guerche‐Séblain C, Paget J. Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: a systematic literature review. Influenza Other Respir Viruses. 2018;12(6):780-92. [DOI:10.1111/irv.12575] [PMID] [PMCID]
6. Tang ML, Li YQ, Chen X, Lin H, Jiang ZC, Gu DL, et al. Co-infection with common respiratory pathogens and SARS-CoV-2 in patients with COVID-19 pneumonia and laboratory biochemistry findings: a retrospective cross-sectional study of 78 patients from a single center in China. Int Med J Experiment Clin Res. 2021;27:e929783-1. [DOI:10.12659/MSM.929783]
7. Halaji M, Hashempour T, Moayedi J, Pouladfar GR, Khansarinejad B, Khashei R, et al. Viral etiology of acute respiratory infections in children in Southern Iran. Rev Soc Bras Med Trop. 2019;52:e20180249. [DOI:10.1590/0037-8682-0249-2018] [PMID]
8. Fourati S, Loubet P. Revisiting diagnostics: multiplex PCR system for rapid diagnosis of respiratory virus infections: can we do better? Clin Microbiol Infect. 2025;31(5):680-3. [DOI:10.1016/j.cmi.2024.12.006] [PMID]
9. Franz A, Adams O, Willems R, Bonzel L, Neuhausen N, Schweizer-Krantz S, et al. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol. 2010;48(4):239-45. [DOI:10.1016/j.jcv.2010.05.007] [PMID] [PMCID]
10. Alvares PA. SARS-CoV-2 and respiratory syncytial virus coinfection in hospitalized pediatric patients. Pediatr Infect Dis J. 2021;40(4):e164-e6. [DOI:10.1097/INF.0000000000003057] [PMID]
11. Sadeghi F, Pournajaf A, Halaji M, Chehrazi M, Amiri FH, Amoli SS, et al. A Large retrospective study of epidemiological characteristics of COVID-19 patients in the North of Iran: Association between SARS-CoV-2 RT-PCR Ct values with demographic data. Int J Clin Pract. 2022;2022:1455708. [DOI:10.1155/2022/1455708] [PMID] [PMCID]
12. Yoshida LM, Suzuki M, Nguyen HA, Le MN, Vu TD, Yoshino H, et al. Respiratory syncytial virus: co-infection and paediatric lower respiratory tract infections. Europ Respir J. 2013;42(2):461-9. [DOI:10.1183/09031936.00101812] [PMID]
13. Halaji M, Pournajaf A, Sadeghi F, Hasanzadeh A, Chehrazi M, Gholinia H, et al. One-year prevalence and the association between SARS-CoV-2 cycle threshold, comorbidity and outcomes in population of Babol, North of Iran (2020-2021). Caspian J Internal Med. 2022;13(Suppl 3):244-53.
14. Alhamadani Y, Hassan R. Study of tissue damage in the respiratory system of patients with COVID-19 in Al-Muthanna Governorate. J Biomed Biochem. 2022;1(3):21-6 [DOI:10.57238/jbb.2022.5654.1019]
15. Ek P, Böttiger B, Dahlman D, Hansen KB, Nyman M, Nilsson AC. A combination of naso-and oropharyngeal swabs improves the diagnostic yield of respiratory viruses in adult emergency department patients. Infect Dis. 2019;51(4):241-8. [DOI:10.1080/23744235.2018.1546055] [PMID] [PMCID]
16. Sadeghi F, Halaji M, Shirafkan H, Pournajaf A, Ghorbani H, Babazadeh S, et al. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves. BMC Infect Dis. 2024;24(1):55. [DOI:10.1186/s12879-023-08939-w] [PMID] [PMCID]
17. Martínez-Roig A, Salvadó M, Caballero-Rabasco M, Sánchez-Buenavida A, López-Segura N, Bonet-Alcaina M. Viral coinfection in childhood respiratory tract infections. Arch Bronconeumol. 2015;51(1):5-9.
https://doi.org/10.1016/j.arbres.2014.01.018 [DOI:10.1016/j.arbr.2014.11.020] [PMID]
18. Wehl G, Laible M, Rauchenzauner M. Co-infection of SARS CoV-2 and influenza A in a pediatric patient in Germany. Klin Pädiatr. 2020;232(04):217-8. [DOI:10.1055/a-1163-7385] [PMID]
19. Adams K, Tastad KJ, Huang S, Ujamaa D, Kniss K, Cummings C, et al. Prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged< 18 years who were hospitalized or died with influenza-United States, 2021-22 Influenza Season. Morbid Mortal Week Rep. 2022;71(50):1589-96. [DOI:10.15585/mmwr.mm7150a4] [PMID] [PMCID]
20. Ren L, Lin L, Zhang H, Wang Q, Cheng Y, Liu Q, et al. Epidemiological and clinical characteristics of respiratory syncytial virus and influenza infections in hospitalized children before and during the COVID‐19 pandemic in Central China. Influ Respir Virus. 2023;17(2):e13103.
21. Burstein B, Lefebvre MA, Bhanji F. Presumed respiratory syncytial virus and severe acute respiratory syndrome coronavirus-2 co-infection in a critically ill infant: Diagnostic uncertainty and emergency management. Canad J Emerg Med. 2020;22(6):877-9. [DOI:10.1017/cem.2020.445] [PMID] [PMCID]
22. Halabi KC, Wang H, Leber AL, Sánchez PJ, Ramilo O, Mejias A. Respiratory syncytial virus and SARS‐CoV‐2 coinfections in children. Pediatr Pulmonol. 2022. [DOI:10.1002/ppul.26127] [PMID] [PMCID]
23. Giannattasio A, Maglione M, D'Anna C, Muzzica S, Angrisani F, Acierno S, et al. Silent RSV in infants with SARS‑CoV‑2 infection: A case series. Pediatr Pulmonol. 2021;56(9):3044. [DOI:10.1002/ppul.25465] [PMID] [PMCID]
24. Scotta MC, Chakr VCBG, de Moura A, Becker RG, de Souza APD, Jones MH, et al. Respiratory viral coinfection and disease severity in children: a systematic review and meta-analysis. J Clin Virol. 2016;80:45-56. [DOI:10.1016/j.jcv.2016.04.019] [PMID] [PMCID]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
